This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Cardiology Biobank Registry

This study is currently recruiting participants.
See Contacts and Locations
Verified July 2016 by Arshed A. Quyyumi, Emory University
Information provided by (Responsible Party):
Arshed A. Quyyumi, Emory University Identifier:
First received: September 19, 2006
Last updated: July 21, 2016
Last verified: July 2016

Statement of the Problem:

Over the last several decades, scientists have made great progress in their understanding of cardiovascular disease. Nevertheless, much remains to be learned about the causes, course, and treatment of cardiovascular disease. In order to learn more about this topic, it is important to establish large databases of cardiovascular patients. These databases allows scientists to investigate, in a rigorous and precise manner, those factors that influence cardiovascular disease.

How the Problem Will Be Studied:

In the present study, we intend to establish a large database of cardiovascular patients. More specifically, we will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Crawford Long Hospital, and Grady Memorial Hospital.

We will collect a large amount of data on these patients. Data to be collected will include information on:

  1. medical history of the patient
  2. medical history of the patient's family
  3. health behaviors of the patient
  4. psychological status of the patient
  5. results of procedures the patient undergoes, such as catheterization/angioplasty/bypass
  6. biochemical markers in patient blood samples, including genetic/DNA markers
  7. follow-up information on patient outcomes such as mortality or re-hospitalization

The data noted above will be collected by:

  1. administering questionnaires/interviews to the patients
  2. accessing the medical records of the patients
  3. collecting blood samples from patients which will be analyzed by laboratories for their biochemical content.

Once the data has been collected, we will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively.

How the Research Will Advance Scientific Knowledge/Human Health:

By collecting a large amount of data on a large number of cardiovascular patients, we will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.

Condition Phase
Cardiovascular Disease Phase 1

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Cardiology Biobank Registry

Further study details as provided by Arshed A. Quyyumi, Emory University:

Primary Outcome Measures:
  • All cause death [ Time Frame: Continuous ]

Secondary Outcome Measures:
  • Cardiovascular death [ Time Frame: Continuous ]
  • Re-hospitalization for heart failure [ Time Frame: Continuous ]

Other Outcome Measures:
  • Myocardial Infarction [ Time Frame: Continuous ]
  • Stroke [ Time Frame: Continuous ]

Biospecimen Retention:   Samples With DNA
60 cc of blood will be obtained from the participant. Blood will be processed and stored in -80F freezers as plasma, serum, extracted DNA and whole blood.

Estimated Enrollment: 12000
Study Start Date: December 2003
Estimated Study Completion Date: April 2020
Estimated Primary Completion Date: March 2020 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
General population & patients presenting to the hospital

Inclusion Criteria:

  • 18 & Older

Exclusion Criteria:

  • Congenital Heart Disease
  • Recent Blood Transfusion (less than a month)
  • Moderate to Severe Anemia
  • Active cancer
  • Physician request for patient not to be included in study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00378924

Contact: Danny J Eapen, MD 404 712 0168
Contact: Salman Sher, MD 404 412 0170

United States, Georgia
Emory School Of Medicine Recruiting
Atlanta, Georgia, United States, 30322
Contact: Danny J Eapen, MD    404-712-0168   
Contact: Salman Sher, MD    404 712 0170   
Principal Investigator: Arshed A Quyyumi, MD         
Sponsors and Collaborators
Emory University
Principal Investigator: Arshed A Quyyumi, MD Emory School Of Medicine
  More Information

Responsible Party: Arshed A. Quyyumi, Professor, Emory University Identifier: NCT00378924     History of Changes
Other Study ID Numbers: IRB00000343
950-2003 ( Other Identifier: Other )
Study First Received: September 19, 2006
Last Updated: July 21, 2016

Additional relevant MeSH terms:
Cardiovascular Diseases processed this record on June 22, 2017